Skip to main content

Closed

FBIO: Fortress Biotech, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-31.8% / yr

Operating margin-84.4%

ROIC-20.9%

Financially safe

Stretched

Debt / equity0.33×

Interest coverage-5.8×

Current ratio2.86×

Valuation

Unrated

P/E ratio0.8×

Fortress Biotech, Inc.

FBIONASDAQ Capital Market·USD·Closed

Fortress Biotech, Inc.

FBIONASDAQ·USD·Closed

$3.13

−4.86%

$3.13

−$0.16 (4.86%)

52W Range

49thpctl

Volume

1.28×avg

Mkt Cap

103.98MUSD

P/E

0.8TTM

Div Yield

–ann

52W Range

49thpctl

Volume

1.28×avg

Market Cap

103.98MUSD

P/E Ratio

0.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings